1. Home
  2. XERS vs CTLP Comparison

XERS vs CTLP Comparison

Compare XERS & CTLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • CTLP
  • Stock Information
  • Founded
  • XERS 2005
  • CTLP 1992
  • Country
  • XERS United States
  • CTLP United States
  • Employees
  • XERS N/A
  • CTLP N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • CTLP EDP Services
  • Sector
  • XERS Health Care
  • CTLP Technology
  • Exchange
  • XERS Nasdaq
  • CTLP Nasdaq
  • Market Cap
  • XERS 628.7M
  • CTLP 574.8M
  • IPO Year
  • XERS 2018
  • CTLP N/A
  • Fundamental
  • Price
  • XERS $5.16
  • CTLP $8.30
  • Analyst Decision
  • XERS Strong Buy
  • CTLP Strong Buy
  • Analyst Count
  • XERS 5
  • CTLP 4
  • Target Price
  • XERS $6.10
  • CTLP $12.50
  • AVG Volume (30 Days)
  • XERS 2.3M
  • CTLP 359.0K
  • Earning Date
  • XERS 05-08-2025
  • CTLP 05-08-2025
  • Dividend Yield
  • XERS N/A
  • CTLP N/A
  • EPS Growth
  • XERS N/A
  • CTLP N/A
  • EPS
  • XERS N/A
  • CTLP 0.19
  • Revenue
  • XERS $222,551,000.00
  • CTLP $285,112,000.00
  • Revenue This Year
  • XERS $31.75
  • CTLP $18.00
  • Revenue Next Year
  • XERS $21.09
  • CTLP $15.55
  • P/E Ratio
  • XERS N/A
  • CTLP $43.48
  • Revenue Growth
  • XERS 29.88
  • CTLP 12.88
  • 52 Week Low
  • XERS $1.72
  • CTLP $5.78
  • 52 Week High
  • XERS $6.07
  • CTLP $11.36
  • Technical
  • Relative Strength Index (RSI)
  • XERS 63.30
  • CTLP 61.55
  • Support Level
  • XERS $4.26
  • CTLP $7.91
  • Resistance Level
  • XERS $4.77
  • CTLP $8.39
  • Average True Range (ATR)
  • XERS 0.28
  • CTLP 0.33
  • MACD
  • XERS 0.08
  • CTLP 0.09
  • Stochastic Oscillator
  • XERS 91.32
  • CTLP 98.26

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About CTLP Cantaloupe Inc.

Cantaloupe Inc operates in the small ticket electronic payments industry. It provides wireless, cashless, micro-transactions, and networking services within the unattended Point of Sale (POS) market. Its products and services portfolio consists of ePort Cashless devices, eSuds, EnergyMisers, and Value-added services which include Loyalty and Prepaid, Intelligent Vending, and others. The company offers services to different industries covering car wash, taxi and transportation, laundry, vending, kiosk, amusement, and arcade. The company derives revenue from the sale or lease of equipment and services to the small ticket, unattended POS market, and the majority of its revenue is derived from subscription and transaction fees.

Share on Social Networks: